ARDELYX, INC.

Profile

Company Names

ARDELYX, INC.

Addresses

34175 ARDENWOOD BLVD., SUITE 200, FREMONT, CA 94555

34175 ARDENWOOD BLVD., FREMONT, CA 94555

Phone Numbers

510-745-7047

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$210,363,994.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2016-07-18 
$110,000,008.00 
$110,000,008.00 
$0.00 
Equity 
3
2015-06-05 
$77,771,627.00 
$107,996,652.00 
$30,225,025.00 
Equity 
2
2011-06-23 
$17,578,665.00 
$22,283,445.00 
$4,704,780.00 
Equity 
1
2010-11-16 
$5,013,694.00 
$10,027,388.00 
$5,013,694.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
 
BAZEMORE 
DIRECTOR
ARDELYX, INC.   |  NUVATION BIO INC.
WILLIAM 
 
BERTRAND, JR. 
DIRECTOR
ARDELYX, INC.
JEREMY 
 
CALDWELL 
EXECUTIVE OFFICER
ARDELYX, INC.   |  MISTRAL THERAPEUTICS, INC.   |  CHINOOK THERAPEUTICS U.S., INC.   |  JENGU THERAPEUTICS, INC.
DOMINIQUE 
 
CHARMOT 
EXECUTIVE OFFICER, DIRECTOR
ARDELYX, INC.
DAVID 
 
COLLIER 
DIRECTOR
GENESIS TODAY, INC.   |  AUSPEX PHARMACEUTICALS, INC.   |  ARCADIA BIOSCIENCES, INC.   |  ARCION THEREAPEUTICS INC   |  ARCION THERAPEUTICS, INC.   |  SORBENT THERAPEUTICS INC   |  ARDELYX, INC.   |  VERALIGHT INC   |  LDD HOLDINGS, LLC   |  SURGIQUEST INC   |  EXELA HOLDINGS INC   |  REEVE FOUNDATION - PRESIDIO PARTNERS NRT, L.P.   |  MENLO THERAPEUTICS, INC.   |  EIS HOLDCO, LLC
JEAN 
 
FRECHET 
DIRECTOR
ARDELYX, INC.
ELIZABETH 
 
GRAMMER 
EXECUTIVE OFFICER
ARDELYX, INC.
JEFF 
 
JACOBS 
EXECUTIVE OFFICER
PROSPER MARKETPLACE INC   |  INITIAL STATE TECHNOLOGIES, INC.   |  ARDELYX, INC.
ANNALISA 
 
JENKINS 
DIRECTOR
PROSENSA HOLDING N.V.   |  BIOTHERA HOLDING CORP.   |  DIMENSION THERAPEUTICS, INC.   |  ARDELYX, INC.   |  ONCOSEC MEDICAL INC   |  VIUM, INC.   |  AGEX THERAPEUTICS, INC.   |  COCOON BIOTECH INC.   |  SKYE BIOSCIENCE, INC.   |  ETIRARX, INC.
MARK 
 
KAUFMANN 
EXECUTIVE OFFICER
ARDELYX, INC.
PAUL 
 
KORNER 
EXECUTIVE OFFICER
ARDELYX, INC.   |  VOLTRON THERAPEUTICS, INC.
DAVID 
 
MOTT 
DIRECTOR
3-V BIOSCIENCES, INC.   |  TESARO, INC.   |  ARDELYX, INC.   |  ZYNGENIA, INC.   |  OMTHERA PHARMACEUTICALS, INC.   |  MERSANA THERAPEUTICS INC   |  CYDAN, LLC   |  EDIMER PHARMACEUTICALS, INC.   |  PROSENSA HOLDING N.V.   |  ADAPTIMMUNE LTD   |  MERSANA THERAPEUTICS, INC.   |  XTUIT PHARMACEUTICALS, INC.   |  IMARA INC.   |  COMPLEXA INC.   |  CYDAN II, INC.   |  TIBURIO THERAPEUTICS INC.
MICHAEL 
 
RAAB 
EXECUTIVE OFFICER, DIRECTOR
ARDELYX, INC.   |  TEMPEST THERAPEUTICS, INC.   |  TEMPEST THERAPEUTICS, INC.
GORDON 
 
RINGOLD 
DIRECTOR
ALAVITA PHARMACEUTICALS INC   |  ALEXZA PHARMACEUTICALS INC.   |  3-V BIOSCIENCES, INC.   |  MAVERIX BIOMICS, INC.   |  PROTEIN METRICS INC.   |  ARDELYX, INC.   |  SAGIMET BIOSCIENCES INC.   |  APEXIGEN, INC.   |  MAXYMUNE THERAPEUTICS, INC.
RICHARD 
 
RODGERS 
DIRECTOR
LOSO, INC.   |  FOUNDATIONS RECOVERY NETWORK LLC   |  3-V BIOSCIENCES, INC.   |  ARDELYX, INC.   |  SAGIMET BIOSCIENCES INC.   |  OPUS GENETICS, INC.
DAVID 
 
ROSENBAUM 
EXECUTIVE OFFICER
ZOO ENTERTAINMENT, INC   |  WHI REAL ESTATE PARTNERS I, L.P.   |  WHI REAL ESTATE PARTNERS I-F, L.P.   |  WHI L+B FOUNDERS FUND LLC   |  WHI REAL ESTATE PARTNERS II, L.P.   |  WHI REAL ESTATE PARTNERS II-PF, L.P.   |  WHI REAL ESTATE PARTNERS II-TE, L.P.   |  WHIREP II REIT INC.   |  WHI REAL ESTATE PARTNERS III, L.P.   |  WHI REAL ESTATE PARTNERS III-TE, L.P.   |  WHI REAL ESTATE PARTNERS III-PF, L.P.   |  ARDELYX, INC.   |  WHI REAL ESTATE PARTNERS IV, L.P.   |  WHI REAL ESTATE PARTNERS IV-B, L.P.   |  WHI REAL ESTATE PARTNERS IV-PF, L.P.   |  WHI REAL ESTATE PARTNERS IV-TE, L.P.   |  WHIREP ROSEVILLE CO-INVEST, L.P.   |  WHIREP SAT CO-INVEST, L.P.   |  PLANET DIGITAL PARTNERS, INC.   |  WHI REAL ESTATE PARTNERS V-TE, L.P.   |  WHI REAL ESTATE PARTNERS V, L.P.   |  WHIREP V REIT LLC   |  LANDROCK 1330 SOUTHERN CO-INVEST, L.P.   |  LANDROCK REAL ESTATE PARTNERS VIII, L.P.   |  LANDROCK REAL ESTATE PARTNERS VIII-TE, L.P.   |  LANDROCK VIII REIT LLC   |  LANDROCK 505 CO-INVEST, L.P.   |  LAKE RIVER MRP REIT, LLC   |  LANDROCK FLYOVER CO-INVEST, L.P.
PETER 
 
SCHULTZ 
DIRECTOR
ARDELYX, INC.   |  RESET THERAPEUTICS, INC.
PETER 
G. 
SCHULTZ 
DIRECTOR
AMBRX INC   |  WILDCAT DISCOVERY TECHNOLOGIES, INC   |  ARDELYX, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-08-01
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-07-18 
2015-06-22
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-06-05 
2011-07-07
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-06-23 
2010-12-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2010-11-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LEERINK PARTNERS LLC
39011